Lakewood-Amedex doses first patient in Nu-3 diabetic ulcer trial
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Health & Medicine
New framework aims to standardize lifestyle medicine data collection across health care systems
As health care systems increasingly seek solutions to the growing burden of chronic disease, a new position statement from the American College of Lifestyle Medicine (ACLM) outlines a standardized…
What faith-based communities understand about public health
One of the most powerful drivers of health is something hard to measure: hope and the relationships that help people hold onto it.
Merck’s return to ophthalmology snags first success
Merck’s $1.3 billion upfront bet on EyeBio in 2024 is starting to pay off. The New Jersey drug giant, attempting to expand its therapeutic arsenal beyond Keytruda, reported ...